Kukje Pharma Co., Ltd.
Símbolo: 002720.KS
KSC
4940
KRWPrecio de mercado actual
-11.8884
Ratio PER
-0.1069
Ratio PEG
100.04B
Capitalización MRK
- 0.00%
Rendimiento DIV
Kukje Pharma Co., Ltd. (002720-KS) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 41530.25 | 10632.2 | 5559.1 | 7903 | |||||||||||||||||
balance-sheet.row.short-term-investments | 122.85 | 42.3 | 20.2 | 36.9 | |||||||||||||||||
balance-sheet.row.net-receivables | 87640.04 | 22141.3 | 20741.2 | 23753.9 | |||||||||||||||||
balance-sheet.row.inventory | 86355.78 | 21243.1 | 22235.2 | 16540.4 | |||||||||||||||||
balance-sheet.row.other-current-assets | 2335 | 2335 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-current-assets | 217861.08 | 56351.6 | 48535.5 | 48197.3 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 329892.77 | 99124 | 78379.8 | 81980.9 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.intangible-assets | 3942.6 | 919.3 | 1125.4 | 1333.3 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3942.6 | 919.3 | 1125.4 | 1333.3 | |||||||||||||||||
balance-sheet.row.long-term-investments | 18994.8 | 7199.4 | 3963.4 | 3915.7 | |||||||||||||||||
balance-sheet.row.tax-assets | 10766.12 | 6128.1 | 6961.3 | 4355.9 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 9463.88 | 897.6 | -2372.5 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 373060.16 | 114268.3 | 88057.4 | 91585.7 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 590921.24 | 170619.9 | 136592.9 | 139783 | |||||||||||||||||
balance-sheet.row.account-payables | 32633.62 | 8564 | 7068.4 | 7249 | |||||||||||||||||
balance-sheet.row.short-term-debt | 118212 | 30186.3 | 27399.9 | 34366.4 | |||||||||||||||||
balance-sheet.row.tax-payables | 7944.12 | 1582.5 | 1487.9 | 302.5 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 3837.24 | 475.7 | 1196.1 | 1620.3 | |||||||||||||||||
Deferred Revenue Non Current | 1259.56 | 352.9 | 296.9 | 7810.2 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 44294.01 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 29280.16 | 19231.6 | 10360.7 | 46.2 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 71241.38 | 25966.4 | 14658.5 | 16678.6 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 4862.9 | 475.7 | 1596 | 1986.6 | |||||||||||||||||
balance-sheet.row.total-liab | 296436.17 | 85670.4 | 62513.6 | 71195.2 | |||||||||||||||||
balance-sheet.row.preferred-stock | 47055.35 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 83674.65 | 21159.8 | 20195.1 | 19276.1 | |||||||||||||||||
balance-sheet.row.retained-earnings | -2236.25 | -8381 | 6327 | 1094.5 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 140979.6 | 72637.1 | 47028 | 48633.8 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 24989.47 | -471.8 | 523.9 | -436.4 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 294462.81 | 84944.1 | 74074.1 | 68568.1 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 590915.08 | 170619.9 | 136592.9 | 139783 | |||||||||||||||||
balance-sheet.row.minority-interest | 22.26 | 5.5 | 5.2 | 19.7 | |||||||||||||||||
balance-sheet.row.total-equity | 294485.07 | 84949.6 | 74079.3 | 68587.8 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 590915.08 | - | - | - | |||||||||||||||||
Total Investments | 19117.65 | 7241.7 | 3983.6 | 3952.6 | |||||||||||||||||
balance-sheet.row.total-debt | 122049.25 | 30662.1 | 28596 | 35986.6 | |||||||||||||||||
balance-sheet.row.net-debt | 80641.85 | 20072.2 | 23057.1 | 28120.6 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -8414.22 | -8415.2 | 3542.8 | -1555.8 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 4204.13 | 4204.1 | 4488 | 4419 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 5428.79 | 5428.8 | -4274.2 | 5597.3 | |||||||||||||||||
cash-flows.row.account-receivables | 565.75 | 565.8 | 4648.4 | 4595.1 | |||||||||||||||||
cash-flows.row.inventory | 1289.7 | 1289.7 | -4789.1 | 3261.1 | |||||||||||||||||
cash-flows.row.account-payables | 11579.3 | 11579.3 | 711.1 | 933.2 | |||||||||||||||||
cash-flows.row.other-working-capital | -8005.96 | -8006 | -4844.7 | -3192 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 2356.48 | 2357.4 | 2747.3 | 1136.6 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 3575.18 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -1045.9 | -1045.9 | -1276.8 | -1960.6 | |||||||||||||||||
cash-flows.row.acquisitions-net | 35.74 | 35.7 | 81.4 | -45.1 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -50 | -50 | 0 | -1462.2 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 510 | 510 | 0 | 100.7 | |||||||||||||||||
cash-flows.row.other-investing-activites | -624.89 | -624.9 | -151.5 | -14.6 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -1175.05 | -1175.1 | -1346.9 | -3381.8 | |||||||||||||||||
cash-flows.row.debt-repayment | -7900 | -3000 | -7000 | -2000 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | -31.07 | -31.1 | -40.6 | -45.5 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.other-financing-activites | 10692.44 | 5641.1 | -433 | -388.4 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 2609.99 | 2610 | -7473.6 | -2433.9 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 40.82 | 40.8 | -10.4 | 71.7 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 5050.94 | 5050.9 | -2327.1 | 3853 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 41407.4 | 10589.9 | 5538.9 | 7866.1 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 36356.46 | 5538.9 | 7866.1 | 4013 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 3575.18 | 3575.2 | 6503.8 | 9597.1 | |||||||||||||||||
cash-flows.row.capital-expenditure | -1045.9 | -1045.9 | -1276.8 | -1960.6 | |||||||||||||||||
cash-flows.row.free-cash-flow | 2529.29 | 2529.3 | 5227 | 7636.5 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 135372.69 | 135372.7 | 126583.4 | 119745.6 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 68290.41 | 68907.7 | 63329.3 | 65275.3 | |||||||||||||||||
income-statement-row.row.gross-profit | 67082.28 | 66465 | 63254.1 | 54470.3 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 2506.56 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 39427.26 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 36229.06 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -33387.44 | -2249.3 | 28438.4 | 27046.3 | |||||||||||||||||
income-statement-row.row.operating-expenses | 31258.31 | 68454.1 | 57981.6 | 56146.2 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 101671.11 | 137361.8 | 121310.9 | 121421.5 | |||||||||||||||||
income-statement-row.row.interest-income | 394.02 | 394 | 230.9 | 114.3 | |||||||||||||||||
income-statement-row.row.interest-expense | 1439.89 | 1439.9 | 1000.5 | 696.4 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 36229.06 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -4691.47 | -4691.5 | -527.4 | -709 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -33387.44 | -2249.3 | 28438.4 | 27046.3 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -4691.47 | -4691.5 | -527.4 | -709 | |||||||||||||||||
income-statement-row.row.interest-expense | 1439.89 | 1439.9 | 1000.5 | 696.4 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 22365.8 | 4204.1 | 5487.9 | 4419 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 36063.55 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -1989.14 | -1989.1 | 5272.5 | -401.3 | |||||||||||||||||
income-statement-row.row.income-before-tax | -6680.61 | -6680.6 | 4745.1 | -1110.3 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 1734.28 | 1734.3 | 1202.3 | 445.5 | |||||||||||||||||
income-statement-row.row.net-income | -8415.19 | -8415.2 | 3557.3 | -1555.8 |
Preguntas frecuentes
Cuánto es Kukje Pharma Co., Ltd. (002720.KS) activos totales?
Kukje Pharma Co., Ltd. (002720.KS) los activos totales son 170619924207.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son 67420082316.000.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.496.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es 124.893.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es -0.062.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son -0.015.
¿Qué es Kukje Pharma Co., Ltd. (002720.KS) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es -8415187456.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 30662085312.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 68454126265.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 10589867418.000.